Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FJY74
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,459
Award facts
- Contract value 100% obligated
- $61,458.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $61,458.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 300 mg/2 mL syringes. The contract, which is not set-aside and was competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will be completed by September 18, 2025, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, delivers comprehensive medical supplies to support military and veteran healthcare systems through this arrangement. Dupixent is a biologic medication used to treat conditions including eczema, asthma, and chronic rhinosinusitis, making this delivery order part of the Defense Health Agency's broader pharmaceutical supply chain supporting military medical readiness. The parent IDC vehicle enables AmerisourceBergen to supply a diverse pharmaceutical portfolio across multiple therapeutic domains to federal customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key supplier within the DLA Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DB25FJY74?
SPE2DB25FJY74 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FJY74 worth?
The government has obligated $61,459 on SPE2DB25FJY74.
Is contract SPE2DB25FJY74 an order under another contract?
Yes. SPE2DB25FJY74 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJY74 competed?
The extent of competition for SPE2DB25FJY74 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award